PubMed Health⌕ Search

Biomedical subjects

Hideki Sugimoto

Publications and source records attributed to Hideki Sugimoto.

24 records · Page 2Linked to original sources
PubMed2003

The relation of clinical symptoms and anti-ganglioside antibodies to MEPPs frequency increase in 8 cases of variant type Guillain-Barré syndrome.

Many patients with variant forms of Guillain-Barré syndrome (vGBS) associated with anti-ganglioside antibodies, including Miller Fisher syndrome (MFS), sometimes exhibit miniature endplate potential (MEPP) frequency increases (MFI, described as alpha-latrotoxin-like effects in a previous report) and the factor to produce this effect is present in their sera. MFI-positive sera increase the frequency of MEPPs, then block neuromuscular transmission at the mouse neuromuscular junction. A connection between this effect at the neuromuscular junction and some vGBS symptoms is suspected. We measured MFI directly at several points during the clinical course of 8 vGBS patients who had various symptoms and courses. Six patients had confirmed MFI and this activity decreased with convalescence. In 3 clinically mild cases, we were able to elicit MFI using normal serum to supply complement after exposure to the patient's serum. The anti-GQ1b/GT1a IgG titer, the extent of ophthalmoplegia and the extent of MFI were significantly correlated. They did not correlate with the severity of limb weakness or the occurrence of respiratory failure. These results support the hypothesis that MFI caused by anti-ganglioside antibodies is the pathogenic mechanism responsible for ophthalmoplegia in vGBS; different mechanisms or antibodies may explain limb weakness and respiratory failure. Furthermore, MFI may be an important indicator of how serum injures the nerve terminals. The symptoms of vGBS may result from multiple pathogenic factors.

Adult↗
PubMed2002

[A case of Fahr's disease presenting "diffuse neurofibrillary tangles with calcification"].

77-year-old woman presented memory disturbance, hallucination, and personality change since the summer of 1988. Laboratory findings revealed normal serum Ca, P, HS-PTH levels and Ellsworth-Howard test was intact. Neuroradiological studies disclosed calcification in the dentate nucleus, putamen, globus pallidus and thalamus. We made a diagnosis of Fahr's disease. During the follow-up period of 13 years, brain MRI showed gradual atrophy in temporal lobes. This case was characterized by the clinical and neuroradiological findings of "diffuse neurofibrillary tangles with calcification: DNTC". We discussed the relations of Fahr's disease and DNTC in the literatures. From our long time observation of this case, we suggest that Fahr's disease includes DNTC.

Aged↗
PubMed1996

Preparation, Structure, and Properties of Bis(&mgr;-oxo)dirhenium(III,IV) and -dirhenium(IV) Complexes of Tris(2-pyridylmethyl)amine and Its (6-Methyl-2-pyridyl)methyl Derivatives.

A series of bis(&mgr;-oxo)dirhenium complexes, [Re(2)(&mgr;-O)(2)(L)(2)](PF(6))(n)() (L = tris(2-pyridylmethyl)amine (tpa), n = 3 (1), n = 4 (1a); L = ((6-methyl-2-pyridyl)methyl)bis(2-pyridylmethyl)amine (Metpa), n = 3 (2), n = 4 (2a); bis((6-methyl-2-pyridyl)methyl)(2-pyridylmethyl)amine (Me(2)tpa), n = 3 (3), n = 4 (3a)), have been prepared and characterized by several physical methods. X-ray crystallographic studies for 2, 2a.2CH(3)CN.2H(2)O (2a'), and 3a' (ReO(4)(-) salt), include the first structural determinations of (i) the bis(&mgr;-oxo)-Re(III)Re(IV) complex (2) and (ii) the pair of Re(III)Re(IV) and Re(IV)(2) complexes (2 and 2a'). All the complexes have a centrosymmetric structure, suggesting that the mixed-valence state 2 is of structurally delocalized type. The Re-Re distances for 2, 2a.2CH(3)CN.2H(2)O, and 3a' are 2.426(1), 2.368(1), and 2.383(1) Å, respectively, being consistent with the bond order of 2.5 (sigma(2)pi(2)delta(2)delta) for 2 and 3 (sigma(2)pi(2)delta(2)) for the others. Methyl substitution on the pyridyl moiety of the ligands has no significant influence to the overall structure. Cyclic voltammetry of 1 shows two reversible redox waves at -0.77 ((III,III)/(III,IV)) and 0.09 V ((III,IV)/(IV,IV)) vs Ag/AgCl in acetonitrile. The potentials are slightly more positive for 2 (-0.66 and 0.14 V) and 3(-0.64 and 0.20 V). No proton-coupled redox behavior was observed on addition of p-toluenesulfonic acid. Complexes, 1a, 2a, and 3a show a strong visible absorption band at 477 nm (epsilon, 9200 dm(3) mol(-)(1) cm(-)(1)), 482 (11200), and 485 (8700), respectively, which is assigned to the pi-pi transition within the Re(2)(&mgr;-O)(2) core. For the mixed-valence complexes 1, 2, and 3, a strong band is observed in the longer wavelength region (556-572 nm). Crystal data: 2, monoclinic, space group C2/c (No.15), a = 11.799(2) Å, b = 19.457(3) Å, c = 21.742(4) Å, beta = 98.97(1) degrees, Z = 4; 2a', triclinic, space group P&onemacr; (No. 2), a = 13.151(3) Å, b = 13.535(2) Å, c = 10.243(3) Å, alpha = 104.37(2) degrees, beta = 109.02(2) degrees, gamma = 106.87(1) degrees, Z = 1; 3a', monoclinic, space group P2(1)/n (No. 14), a = 13.384(3) Å, b = 14.243(2) Å, c = 13.215(6) Å, beta = 106.88(2) degrees, Z = 2.

Journal Article↗
PubMedDate not supplied

[Dimethyl sulphoxide suppresses hydroxyl radical formation of muscle fiber necrosis induced by bupivacaine hydrochloride].

We induced acute skeletal muscle necrosis by using bupivacaine hydrochloride in Wistar rats and found that both 2,5- and 2, 3-dihydroxybenzoic acid significantly increased in the skeletal muscle. Dimethyl sulphoxide, a free radical scavenger, was administrated for 5 days, and resulted in significant lowering of the concentrations of 2, 5- and 2, 3-dihydroxybenzoic acid for four days. Histologically, the diameter of the regenerated muscle fiber seemed to grow by using dimethyl sulphoxide. Dimethyl sulphoxide may decrease the muscle degeneration. These results suggest that dimethyl sulphoxide is an effective hydroxyl radical scavenger, and may be a candidate for the treatment of myopathy.

Anesthetics, Local↗